CURRENT USES OF SULFONAMIDES IN PEDIATRIC PRACTICE

H. Hodes

DOI: https://doi.org/10.1111/j.1749-6632.1957.tb49676.x

IF: 6.499

1957-10-01

Annals of the New York Academy of Sciences

Abstract:The introduction of penicillin and streptomycin greatly reduced the use of sulfonamides in pediatrics. This trend was accentuated by the discovery of chloramphenicol, the tetracycline drugs, and other antibiotics that are effective when taken by mouth, and by the development of effective oral preparations of penicillin. Nevertheless, the sulfonamide drugs still have a definite place in the therapy of infectious diseases of infancy and childhood. In most instances their role is that of an auxiliary to the generally more effective antibiotics. For treatment of infections caused by meningococci, however, they are the most effective agent available. The use of sulfonamides together with penicillin improves the chance for recovery from pneumococcic meningitis, and the compounds are probably of some value when used with chloramphenicol in the treatment of Hemophilus ir$uenzae meningitis. The sulfonamides are of definite value in the treatment of infections of the urinary tract. Many pediatricians begin the treatment of pyelonephritis with sulfonamides and change to antibiotics only if the clinical course is not satisfactory or if bacteriological studies indicate a need for such change. Sulfonamides are still employed by many physicians for treatment of gastrointestinal infections due to Shigella organisms, as well as for infections of less clearly established etiology. Sulfasuxidine and sulfathalidine are most commonly used for this purpose, but many pediatricians employ sulfadiazine and Gantrisin for these infections. Sulfonamides should not be used for treatment of Salmorzella infections, since chloramphenicol is much superior for this purpose, although it is not as effective as the literature indicates. Similarly, neomycin (given by mouth) is superior to sulfonamides for infantile diarrhea caused by enteropathogenic types of Escherickia coli. Perhaps the most difficult problem regarding the sulfonamides concerns their use in the treatment of infections of the upper respiratory tract. In practice, the pediatrician usually must begin treatment without definite knowledge of the etiological agent. Often he will be forced to treat an infection caused by a virus; in this situation neither sulfonamide nor antibiotic will have a curative effect, although secondary bacterial infection may be prevented. Sometimes, however, the pediatrician may have a fairly good idea that he is dealing with a group A P-hemolytic streptococcus (a sibling may have scarlet fever, for example). Sulfonamides alone should not be used in such cases, nor in others in which the probability is great that a hemolytic streptococcus is the causative agent. Instead, penicillin should be used, because of its greater effectiveness in preventing the occurrence of rheumatic fever and nephritis. We believe that sulfonamide should not be given if a bacterial infection of any kind has extended from the pharynx and tonsils to the middle ear, sinuses, larynx, or trachea, but rather that an antibiotic should be used. This recommendation